Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Summit Global Investments grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 187,208 shares of the biopharmaceutical company’s stock after purchasing an additional 2,687 shares during the quarter. Gilead Sciences […]
Brookmont Capital Management cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,491 shares of the biopharmaceutical company’s stock after selling 326 shares during […]
Moody National Bank Trust Division raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,492 shares of the biopharmaceutical company’s stock after acquiring an additional 2,837 shares during the […]
Ferguson Wellman Capital Management Inc. decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 61.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 105,822 shares of the biopharmaceutical company’s stock after selling 166,358 shares during […]
Perkins Coie Trust Co grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8,127.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,867 shares of the biopharmaceutical company’s stock after acquiring an additional 3,820 shares during the quarter. Perkins […]